相似文献
1
Neurofilament proteins in neurodegenerative diseases.
Cell Mol Life Sci. 2004 Dec;61(24):3057-75. doi: 10.1007/s00018-004-4268-8.
2
Neurofilaments in health and disease.
Prog Nucleic Acid Res Mol Biol. 1998;61:1-23. doi: 10.1016/s0079-6603(08)60823-5.
3
Neurofilament high molecular weight-green fluorescent protein fusion is normally expressed in neurons and transported in axons: a neuronal marker to investigate the biology of neurofilaments.
Neuroscience. 2006;137(1):103-11. doi: 10.1016/j.neuroscience.2005.08.077. Epub 2005 Nov 11.
4
Cyclin-dependent kinase 5 in neurofilament function and regulation.
Neurosignals. 2003 Sep-Oct;12(4-5):252-64. doi: 10.1159/000074627.
5
Neurofilaments and neurological disease.
Bioessays. 2003 Apr;25(4):346-55. doi: 10.1002/bies.10251.
6
Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
Nature. 1995 May 4;375(6526):61-4. doi: 10.1038/375061a0.
7
Human midsized neurofilament subunit induces motor neuron disease in transgenic mice.
Exp Neurol. 2003 Nov;184(1):408-19. doi: 10.1016/s0014-4886(03)00206-1.
8
Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport.
Hum Mol Genet. 2002 Nov 1;11(23):2837-44. doi: 10.1093/hmg/11.23.2837.
9
Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.
Mol Neurobiol. 2008 Aug;38(1):27-65. doi: 10.1007/s12035-008-8033-0. Epub 2008 Jul 23.
10
Post-transcriptional control of neurofilaments in development and disease.
Exp Cell Res. 2007 Jun 10;313(10):2088-97. doi: 10.1016/j.yexcr.2007.02.014. Epub 2007 Feb 27.
引用本文的文献
1
Advancing personalized spinal muscular atrophy care: matching the right biomarker to the right patient at the right time.
J Neurol. 2025 Sep 2;272(9):605. doi: 10.1007/s00415-025-13314-7.
2
Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern.
J Neurol. 2025 Jul 15;272(8):512. doi: 10.1007/s00415-025-13246-2.
3
Diagnostic value of fluid-based non-amyloid biomarkers for Alzheimer's disease and related dementias in a clinic-based cohort from South Asia.
Alzheimers Dement (Amst). 2025 May 27;17(2):e70129. doi: 10.1002/dad2.70129. eCollection 2025 Apr-Jun.
4
The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review.
J Neurol. 2025 May 15;272(6):400. doi: 10.1007/s00415-025-13093-1.
5
Functional and Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels.
Medicina (Kaunas). 2025 Jan 3;61(1):70. doi: 10.3390/medicina61010070.
6
Integrated platform for multiscale molecular imaging and phenotyping of the human brain.
Science. 2024 Jun 14;384(6701):eadh9979. doi: 10.1126/science.adh9979.
7
Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Genes (Basel). 2024 Apr 16;15(4):496. doi: 10.3390/genes15040496.
8
Biofluid biomarkers for Alzheimer's disease.
Front Aging Neurosci. 2024 Apr 10;16:1380237. doi: 10.3389/fnagi.2024.1380237. eCollection 2024.
9
Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease.
J Neurol. 2024 Apr;271(4):2042-2052. doi: 10.1007/s00415-023-12160-9. Epub 2024 Jan 8.
10
Transcriptomic Profiling after In Vitro Δ-THC Exposure Shows Cytoskeletal Remodeling in Trauma-Injured NSC-34 Cell Line.
Pharmaceuticals (Basel). 2023 Sep 7;16(9):1268. doi: 10.3390/ph16091268.
Zotero 插件